Everything below concerns GHRH analog. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-10-17. Numbers and descriptions here follow the published literature rather than marketing material.
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
Tesamorelin acts on the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in intracellular cyclic AMP, which in turn opens ion channels and raises calcium concentrations, leading to release of stored growth hormone into the bloodstream. Because the peptide works through the same receptor as the body's own GHRH, the resulting secretion follows a pulsatile pattern rather than a continuous elevation. The N-terminal modification slows enzymatic breakdown, so the signal persists longer than it would with the unmodified hormone.
Growth hormone released from the pituitary stimulates the liver and other tissues to produce insulin-like growth factor 1, a stable circulating protein that serves as a practical marker of activity. Clinical studies therefore track IGF-1 concentrations alongside the hormone itself, and they commonly measure body composition with imaging rather than relying on body weight alone. Visceral adipose tissue, the fat surrounding abdominal organs, is quantified by computed tomography in the studies that supported approval. Adverse effects reported in trials include injection-site reactions, joint pain, and increases in blood glucose, which is why monitoring accompanies use.
Questions remain about how much of the observed fat reduction reflects direct GHRH-receptor signaling versus the downstream growth hormone and IGF-1 surge. It is also unclear whether the compound produces meaningful benefit in populations without lipodystrophy, since trials in cognitive impairment did not reach their stated goals. Long-term effects on glucose metabolism and on cardiovascular outcomes are not fully characterized. Published work generally describes effects on surrogate markers rather than on hard clinical endpoints, and independent replication of some findings is limited.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Analog of growth hormone-releasing hormone |
| Amino acid length | 44 residues | Matches the native peptide backbone |
| Molecular weight | Approximately 5135 Da | Calculated from the peptide sequence |
| Receptor target | GHRH receptor | Expressed on pituitary somatotroph cells |
| Primary studied use | Visceral fat reduction | Investigated in HIV-associated lipodystrophy |
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
特沙莫瑞林的检测通常依赖反相高效液相色谱和质谱联用。反相色谱可分离肽主峰与缺失序列、氧化产物等杂质，质谱则提供精确质量以确认身份。对于复杂基质中的定量，常采用液相色谱-串联质谱，并配合固相萃取或蛋白沉淀。生物样品中的肽易降解，因此采集和处理条件会影响结果。
稳定性研究通常考察温度、光照、湿度和 pH 对肽链的影响。冻干粉在低温避光条件下较为稳定，复溶后则需控制保存时间并避免反复冻融。肽类可能发生氧化、脱酰胺、水解和聚集，这些变化会改变色谱纯度。强制降解实验用于识别主要降解途径并验证分析方法的专属性。
==== Metabolism ==== Naltrexone is metabolized in the liver mainly by dihydrodiol dehydrogenases into 6β-naltrexol (6β-hydroxynaltrexone). Levels of 6β-naltrexol are 10- to 30-fold higher than those of naltrexone with oral administration due to extensive first-pass metabolism. Conversely, 6β-naltrexol exposure is only about 2-fold higher than that of naltrexone with intramuscular injection of naltrexone in microspheres (brand name Vivitrol). 6β-Naltrexol is an opioid receptor antagonist similarly to naltrexone and shows a comparable binding profile to the opioid receptors. However, 6β-naltrexol is peripherally selective and crosses into the brain much less readily than does naltrexone. In any case, 6β-naltrexol does still show some central activity and may contribute significantly to the central actions of oral naltrexone. Other metabolites of naltrexone include 2-hydroxy-3-methoxy-6β-naltrexol and 2-hydroxy-3-methoxynaltrexone. Following their formation, the metabolites of naltrexone are further metabolized by conjugation with glucuronic acid to form glucuronides. Naltrexone is not metabolized by the cytochrome P450 system and has low potential for drug interactions.
The package aimed to raise $739 billion and authorize $370 billion in spending on energy and climate change, $300 billion in deficit reduction, three years of Affordable Care Act subsidies, prescription drug reform to lower prices, and tax reform. According to an analysis by the Rhodium Group, the bill will lower U.S. greenhouse gas emissions between 31 percent and 44 percent below 2005 levels by 2030. On August 7, 2022, the Senate passed the bill (as amended) on a 51–50 vote, with all Democrats voting in favor, all Republicans opposed, and Vice President Kamala Harris breaking the tie. Biden signed the bill on August 16. Before and during the 2021 United Nations Climate Change Conference (COP26), Biden promoted an agreement that the U.S. and the European Union cut methane emissions by a third by 2030 and tried to add dozens of other countries to the effort. Biden pledged to double climate funding to developing countries by 2024. Also at COP26, the U.S. and China reached a deal on greenhouse gas emission reduction. The two countries are responsible for 40 percent of global emissions. In July 2023, when heat waves hit the United States, Biden announced measures to protect the population and said the heat waves were linked to climate change. In April 2024, he unveiled a plan to protect and restore natural water sources (3.2 million hectares of wetlands and 161,000 km of waterways). Biden protected 674 million acres of land and ocean from natural resource exploitation, more than any other president.
Information was passed on to the federal prosecutor's office, which opened a police investigation in July 2022. Since the original arrests in December 2022, the prosecution has experienced a number of setbacks and delays. In June 2023, the lead investigating judge, Michel Claise, stepped down following accusations of a conflict of interest. Lawyers for the accused sought a judicial review into the way the investigation had been carried out. The Court of Appeal heard arguments in December 2025 and ruled, in February 2026, that the investigation had not been significantly flawed and that the prosecution could proceed. As of April 2026, no trial date had been set. Immediately after the first arrests, the President of the European Parliament, Roberta Metsola, said that the parliament stood firmly against corruption and was co-operating with the police investigation. The full chamber voted to remove Kaili as a vice president; she was also expelled from the Socialists & Democrats group (S&D). In September 2023, the European Parliament revised its rules of procedure and its code of conduct, but the system regarding monitoring and sanctioning remained largely unchanged and lacking in external oversight.
Sources: en.wikipedia.org
=== 241Am === Americium-241 is a candidate isotope with much greater availability than 238Pu. Though 241Am has a half-life of 432 years, which is about five times longer than that of 238Pu and could hypothetically power a device for centuries, missions with more than 10 years were not the subject of the research until 2019. The power density of 241Am is only one-fourth that of 238Pu, and 241Am produces more penetrating radiation through decay chain products than 238Pu and needs more shielding. Its shielding requirements in a RTG are the third lowest: only 238Pu and 210Po require less. With a current global shortage of 238Pu, 241Am is being studied as RTG fuel by ESA and in 2019, UK's National Nuclear Laboratory announced the generation of usable electricity. An advantage over 238Pu is that it is produced as nuclear waste and is nearly isotopically pure. Prototype designs of 241Am RTGs expect 2–2.2 We/kg for 5–50 We RTGs design but in practical testing dropped to 1.3–1.9 We/kg. Americium-241 is currently used in small quantities in household smoke detectors and thus its handling and properties are well-established. However, it decays to neptunium-237, the most chemically mobile among the actinides.
Calcium ions are one type of second messengers and are responsible for many important physiological functions including muscle contraction, fertilization, and neurotransmitter release. The ions are normally bound or stored in intracellular components (such as the endoplasmic reticulum(ER)) and can be released during signal transduction. The enzyme phospholipase C produces diacylglycerol and inositol trisphosphate, which increases calcium ion permeability into the membrane. Active G-protein open up calcium channels to let calcium ions enter the plasma membrane. The other product of phospholipase C, diacylglycerol, activates protein kinase C, which assists in the activation of cAMP (another second messenger).
The two substrates of this enzyme are 5,10-methylenetetrahydrofolate and oxidised nicotinamide adenine dinucleotide (NAD+). Its products are 5,10-methenyltetrahydrofolate, reduced NADH, and a proton. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-NH group of donors with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is 5,10-methylenetetrahydrofolate:NAD+ oxidoreductase. This enzyme is also called methylenetetrahydrofolate dehydrogenase (NAD+). This enzyme participates in one carbon pool by folate.
Sources: en.wikipedia.org
President Bill Clinton's administration Greg Burke (1982), former Fox News correspondent and director the Holy See Press Office Claire Shipman (1986), ABC News correspondent Elizabeth Cohen (1987), CNN's senior medical correspondent Alexandra Wallace (1988), executive producer of NBC Nightly News Soterios Johnson (1990), host of Morning Edition on National Public Radio Alexis Glick (1994), anchorwoman for the Fox Business Network Suzy Shuster (1994), Emmy Award-winning sportscaster with ABC Sports Max Kellerman (1998), boxing commentator and host of HBO World Championship Boxing Gideon Yago (2000), MTV News correspondent Jonathan Lemire (2001), journalist and host of MSNBC's Way Too Early Charlotte MacInnis (2002), China Central Television anchor known by the stage name Ai Hua; host of Growing up with Chinese Buzzy Cohen (2007), Jeopardy! guest host and contestant, co-host of The Chase Meghan McCain (2007), former co-host of The View, blogger and daughter of Arizona senator John McCain
Surrounding skin: Appearance of the surrounding skin can provide clues to underlying disease processes, such as redness/erythema due to cellulitis, maceration due to uncontrolled wound exudate, or eczematous changes due to a chronic irritation (e.g. allergic reaction to wound dressing). Infection: Classic signs of infection are redness, warmth, swelling, odor, and pain out of proportion to wound appearance. Pain: Pain can be nociceptive, neuropathic, or inflammatory, each of which can provide clues to the cause of a wound. Proper pain control is an important consideration in wound management, particularly in burn care where analgesia is often necessary prior to dressing changes. A thorough wound evaluation, particularly evaluation of wound depth and removal of necrotic tissue, should be performed only by a licensed healthcare professional in order to avoid damage to nearby structures, infection, or worsening pain.
== Applications == Because of the ability of acetalated dextran to degrade more rapidly in low pH environments like the phagolysosome of a macrophage or dendritic cell, it has been used as polymeric micro/nanoparticles. Acetalated dextran was originally developed as a vaccine carrier, but has been used for drug delivery, tissue engineering and infectious disease vaccine delivery. Its unique degradation rates have led to finely tuned release of therapeutic proteins and vaccine elements. Ac-DEX has also been shown the allow proteins to be stored outside the cold chain. Formation of nanoparticles with Ac-DEX can be made through standard methods like emulsion, spray drying and electrospray. Using sonication, inorganic nanoparticles have been embedded into Ac-DEX particles to for a composite material for cancer therapy."Prickly Nanoparticles against Cancer". article. Weinheim, Germany. 2017-03-09. Retrieved 2024-09-16. Also they have been used as a core material for cell membrane coating.
Sources: en.wikipedia.org
It is a synthetic analog of growth hormone-releasing hormone, a hypothalamic peptide. It functions as a growth hormone secretagogue acting at pituitary receptors. The classification separates it from direct growth hormone products.
The synthetic peptide incorporates modifications that slow enzymatic breakdown in circulation. Native growth hormone-releasing hormone is short-lived, whereas the analog is designed for greater stability. The core amino acid backbone is largely retained.
The main studied application is reduction of excess visceral abdominal fat in HIV-associated lipodystrophy. Research has measured fat changes through imaging. Findings concern fat distribution rather than overall body weight.
It acts upstream at the pituitary receptor and depends on functioning somatotroph cells to produce any effect. Growth hormone injections bypass that step and deliver the hormone directly. The pharmacokinetic profiles and the resulting feedback on the body's own secretion therefore differ.